Indicateurs
1 Consultations de la notice
- Titre
- CD19 4-1BBL (RO7227166) a Novel Costimulatory Bispecific Antibody Can be Safely Combined with the T-Cell-Engaging Bispecific Antibody Glofitamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Créateurs - sans rôle
- Martin Hutchings - RigshospitaletCarmelo Carlo-Stella - Humanitas UniversityGiuseppe Gritti - Ematologia, AASST PAPA GIOVANNI XXIII, Bergamo, ItalyFrancesc Bosch - Hospital Universitari Vall d'Hebron, Barcelona, SpainFranck Morschhauser - Hematology Department, Lille University Hospital, Lille, FranceWilliam Townsend - University College London Hospitals NHS Foundation TrustFritz Offner - Universitair Ziekenhuis Gent, Ghent, BelgiumHarriet S Walter - The HOPE Clinical Trials Unit, Leicester, United KingdomHerve Ghesquieres - Hospices Civils de LyonRoch Houot - Department of Hematology, Rennes University Hospital, Rennes, FranceGuillaume Cartron - Department of Hematology, CHU Montpellier, Montpellier, FranceNatalie Dimier - Roche Innovation Center Welwyn, Roche Ltd, Welwyn, United KingdomStephen Fowler - Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, SwitzerlandEmma Harrop - Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn, United KingdomSylvia Herter - Roche Innovation Center Zurich, Schlieren, SwitzerlandAbiraj Keelara - Roche Innovation Center Basel,, Roche Pharma Research and Early Development, Basel, SwitzerlandKoorosh Korfi - Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, SwitzerlandJeff Luong - Hoffmann-La Roche Limited, Mississauga, CanadaClaudia Mueller - Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, GermanyRobert Nutbrown - Roche Innovation Center Welwyn, Roche Pharama Research and Early Development, Welwyn, United KingdomGiuseppe Palldino - A4P Consulting Ltd., Sandwich, United KingdomMatt Whayman - Roche Innovation Center Welwyn, Roche Ltd, Welwyn, United KingdomIsabel Prieto - Roche Innovation Center Welwyn, Roche Ltd., Welwyn, United KingdomSarah Louise Mycroft - Roche Innovation Center Welwyn, Roche Ltd, Welwyn, United KingdomDaria Rukina - Roche Innovation Center Basel, Roche, Pharma Research Early Development, Basel, SwitzerlandKatharina E Lechner - Roche Innovation Center Munich, Roche Pharma Research and Early Development, Munich, GermanyMichael Dickinson - Peter MacCallum Cancer Centre
- Détails de publication
- Blood, Vol.140(Supplement 1), pp.9461-9463
- Éditeur
- Elsevier Inc
- Nombre de pages
- 3
- Identifiants
- 99139761609311
- Unité académique
- Institut de Génétique Moléculaire de Montpellier - IGMM
- Langue
- English
- Type de ressource
- Journal article